| Financial Year |
March 31 2023 |
| Monetary Funds |
103,755,237.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,560,730.78 |
| Accounts Receivable |
297,595,501.53 |
| Advances to Suppliers |
19,587,762.67 |
| Other Receivables |
415,528.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
114,598,502.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,519,487.77 |
| Total Current Assets |
760,541,498.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,168,131.61 |
| Investment Properties |
-- |
| Fixed Assetes |
137,139,406.28 |
| Under-construction Projects |
20,377,245.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,256,063.02 |
| R&D expenses |
-- |
| Goodwill |
132,359,801.90 |
| Long-Term Deferred and Prepaid Expenses |
6,410,940.95 |
| Deferred Income Tax Assets |
10,836,997.75 |
| Other Non-Current Assets |
12,658,773.13 |
| Sub-Total of Non-Current Assets |
400,718,866.75 |
| Total Assets |
1,161,260,365.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
177,943,415.20 |
| Accounts Payable |
126,562,127.83 |
| Accounts Received In Advance |
140,960.00 |
| Employee Compensation Payable |
7,374,484.23 |
| Taxes Payable |
9,942,304.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,166,597.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,465,710.19 |
| Other Current Liabilities |
112,490.19 |
| Sub-Total of Current Liabilities |
328,573,398.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,072,538.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,137,731.71 |
| Total Liabilities |
368,711,130.52 |
| Paid-In Capital(Or Share Stock) |
213,454,755.00 |
| Capital Surplus |
226,876,497.43 |
| Surplus Reserve |
28,785,234.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
316,313,197.71 |
| Minority Stockholder's Interest |
7,119,550.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
785,429,684.57 |
| Owner's Equity（Stockholder's Equity） |
792,549,234.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,161,260,365.28 |
